日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The T-cell response to SARS-CoV- 2 vaccination persists beyond six months in rheumatoid arthritis patients treated with rituximab

在接受利妥昔单抗治疗的类风湿性关节炎患者中,SARS-CoV-2疫苗接种后的T细胞反应可持续超过六个月。

Marin, Juliette; Bourgoin, Penelope; Saverna, Noemie; Cartagena, Celia; Lafforgue, Pierre; Busnel, Jean-Marc; Balandraud, Nathalie

My highlights as Editor-in-Chief of Clinical & Experimental Immunology, 2017–2024

我担任《临床与实验免疫学》主编期间(2017-2024 年)的主要成就

Bertin, Daniel; Aghzadi, Jehanne; Balandraud, Nathalie; Roman, Céline; Serrero, Mélanie; Desplat-Jégo, Sophie; Taams, Leonie S

COVID-19 presentation and outcomes in patients with inflammatory rheumatic and musculoskeletal diseases receiving IL6-receptor antagonists prior to SARS-CoV-2 infection

在感染SARS-CoV-2之前接受IL-6受体拮抗剂治疗的炎症性风湿病和肌肉骨骼疾病患者中,COVID-19的临床表现和预后

Comarmond, Cloé; Drumez, Elodie; Labreuche, Julien; Hachulla, Eric; Thomas, Thierry; Flipo, René-Marc; Seror, Raphaëlle; Avouac, Jérôme; Balandraud, Nathalie; Desbarbieux, Renaud; Felten, Renaud; Gilson, Mélanie; Guyot, Marie-Hélène; Hittinger-Roux, Ambre; Pham, Thao; Renard, Myriam; Roux, Nicolas; Sobanski, Vincent; Tournadre, Anne; Richez, Christophe; Cacoub, Patrice

UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial

UCART19 是一种首创的同种异体抗 CD19 嵌合抗原受体 T 细胞疗法,用于治疗复发或难治性 B 细胞急性淋巴细胞白血病 (CALM) 成人患者:一项 1 期剂量递增试验

Benjamin, Reuben; Jain, Nitin; Maus, Marcela V; Boissel, Nicolas; Graham, Charlotte; Jozwik, Agnieszka; Yallop, Deborah; Konopleva, Marina; Frigault, Matthew J; Teshima, Takanori; Kato, Koji; Boucaud, Floriane; Balandraud, Svetlana; Gianella-Borradori, Athos; Binlich, Florence; Marchiq, Ibtissam; Dupouy, Sandra; Almena-Carrasco, Maria; Pannaux, Matthieu; Fouliard, Sylvain; Brissot, Eolia; Mohty, Mohamad

Biomarkers in psoriatic arthritis: A meta-analysis and systematic review

银屑病关节炎的生物标志物:一项荟萃分析和系统评价

Wirth, Theo; Balandraud, Nathalie; Boyer, Laurent; Lafforgue, Pierre; Pham, Thao

How RA Associated HLA-DR Molecules Contribute to the Development of Antibodies to Citrullinated Proteins: The Hapten Carrier Model

类风湿关节炎相关HLA-DR分子如何促进抗瓜氨酸化蛋白抗体的产生:半抗原载体模型

Roudier, Jean; Balandraud, Nathalie; Auger, Isabelle

Leveraging whole blood based functional flow cytometry assays to open new perspectives for rheumatoid arthritis translational research

利用全血功能性流式细胞术检测为类风湿性关节炎转化研究开辟新前景

Cartagena García, Celia; Balandraud, Nathalie; Roudier, Jean; Lafforgue, Pierre; Lambert, Nathalie; Busnel, Jean-Marc

The Longitudinal Compression Capacity of Hollow Concrete Cylinders Prestressed by Means of an SMA Wire

采用形状记忆合金丝预应力的空心混凝土圆柱体的纵向抗压性能

Dębska, Aleksandra; Gwoździewicz, Piotr; Seruga, Andrzej; Balandraud, Xavier; Destrebecq, Jean-François

Clinical Pharmacology and Determinants of Response to UCART19, an Allogeneic Anti-CD19 CAR-T Cell Product, in Adult B-cell Acute Lymphoblastic Leukemia

成人 B 细胞急性淋巴细胞白血病对同种异体抗 CD19 CAR-T 细胞产品 UCART19 的临床药理学和反应决定因素

Sandra Dupouy, Ibtissam Marchiq, Thibaud Derippe, Maria Almena-Carrasco, Agnieszka Jozwik, Sylvain Fouliard, Yasmina Adimy, Julia Geronimi, Charlotte Graham, Nitin Jain, Marcela V Maus, Mohamad Mohty, Nicolas Boissel, Takanori Teshima, Koji Kato, Reuben Benjamin, Svetlana Balandraud

First flare of ACPA-positive rheumatoid arthritis after SARS-CoV-2 infection

SARS-CoV-2感染后ACPA阳性类风湿性关节炎首次发作

Perrot, Lea; Hemon, Marie; Busnel, Jean-Marc; Muis-Pistor, Olivier; Picard, Christophe; Zandotti, Christine; Pham, Thao; Roudier, Jean; Desplat-Jego, Sophie; Balandraud, Nathalie